dc.contributor.author | Cohen, Malkiel | |
dc.contributor.author | Wert, Katherine | |
dc.coverage.temporal | Spring 2015 | |
dc.date.accessioned | 2023-03-06T17:26:22Z | |
dc.date.available | 2023-03-06T17:26:22Z | |
dc.date.issued | 2015-06 | |
dc.identifier | 7.342-Spring2015 | |
dc.identifier.other | 7.342 | |
dc.identifier.other | IMSCP-MD5-2ac9f88a2126b95d8efdbdfef59b3ef0 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/148355 | |
dc.description.abstract | One of the major priorities in biomedical research is understanding the molecular events that establish the complex processes involved in human development and the relationships of these processes to human disease and disease progression. In this class, we will explore stem cell biology and the way in which it has developed and shaped our ability to study complex human disease. We will introduce the field of stem cell biology and genome engineering through critical reading of both the classical and newest primary research literature. In addition, this course will discuss specific disease model systems and their benefits / limitations for understanding the disease and treating human patients. This course is one of many Advanced Undergraduate Seminars offered by the Biology Department at MIT. These seminars are tailored for students with an interest in using primary research literature to discuss and learn about current biological research in a highly interactive setting. Many instructors of the Advanced Undergraduate Seminars are postdoctoral scientists with a strong interest in teaching. | en |
dc.language.iso | en-US | |
dc.rights | This site (c) Massachusetts Institute of Technology 2023. Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license ("CCPL" or "license") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions. | en |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 Unported | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | * |
dc.subject | stem cells | en |
dc.subject | genome engineering | en |
dc.subject | pluripotency | en |
dc.subject | disease progression | en |
dc.subject | embryonic stem cells | en |
dc.subject | induced pluripotent stem cells | en |
dc.subject | transgenic animals | en |
dc.subject | regenerative medicine | en |
dc.subject | CRISPR/cas9 | en |
dc.subject | Nuclear Transfer | en |
dc.subject | Cellular Reprogramming | en |
dc.title | 7.342 Pluripotent Stem Cells and Genome Engineering for Modeling Human Diseases, Spring 2015 | en |
dc.title.alternative | Pluripotent Stem Cells and Genome Engineering for Modeling Human Diseases | en |
dc.audience.educationlevel | Undergraduate | |
dc.subject.cip | 260210 | en |
dc.date.updated | 2023-03-06T17:26:28Z | |